This study compared the effects of supplementation with a polyphenol-rich pomace from strawberry (US) and a strawberry pomace without most of these compounds (PS) on gastrointestinal, blood, and tissue biomarkers in rats fed diets differing in carbohydrate contents for 4 wk. The diets were: corn starch (group CS), high fructose (60% by weight; group F), starch with 7.7% of either US or PS (groups CS+US and CS+PS, respectively), and high fructose with 7.7% of either US or PS (groups F+US and F+PS, respectively). An interaction (P , 0.05) was observed between diet type and strawberry preparation, showing that upon fructose feeding, US had a greater effect than PS on lowering serum insulin, liver total cholesterol, and conjugated dienes. Additionally, the F+US group had lower serum FFA than the F+PS group (P , 0.05). The extraction of polyphenols diminished the physiological effect associated with strawberry intake, suggesting that the fiber component of the pomace was also active in reducing metabolic complications following fructose feeding to rats.
Introduction
Recently, there has been notable interest in colored fruits as sources of biologically and physiologically active substances. Numerous scientific data have revealed that dietary intake of berries has a positive impact on human health and disease (1) (2) (3) (4) . Among these fruits, the strawberry is one of the most commonly cultivated and consumed, both in fresh and processed form. The beneficial effects of strawberries are attributed to individual classes of polyphenols based on in vitro or animal model studies; however, the majority of attention has been paid to the antioxidative potential of the fruit constituents (3) . In strawberries, the major phenolic antioxidants include ellagic acid, quercetin, and anthocyanin, such as cyanidin glucosides. Anthocyanins have also been proved to minimize development of obesity in some animal models fed an obesogenic diet (5) . Moreover, strawberries are rich sources of complex phenolic polymers, like ellagitannins, which possess antimicrobial activities against human gastrointestinal pathogens (2,6). Another potential advantage of consuming strawberries is that they have been shown to reduce blood lipids (4) . However, due to the short shelf life of strawberries, fruits are not available throughout the year. Strawberry pomace, a by-product from industrial fruit processing, also constitutes a promising source of antioxidants and micronutrients and could therefore be an alternative and cost-effective way of supplementing human diet with strawberry polyphenols.
Numerous studies have reported that high dietary intake of fructose is associated with various adverse metabolic disturbances in animal models, including hypertriglyceridemia, hyperinsulinemia, and hypertension (7) (8) (9) . The objective of this work was to investigate whether the presence of strawberry pomace in the diet may influence fructose-induced metabolic abnormalities in rats when used as an experimental model. To assess which component of pomace is responsible for the possible effect, experimental diets were supplemented with two different strawberry preparations: native US 6 abundant in polyphenols and a PS depleted from most of these compounds via water and ethanol extraction. Given the observed effects of polyphenols on metabolicrelated indices, we expected that strawberry-enriched diets would decrease disturbances associated with high fructose administration. Because fructose is poorly absorbable when provided in excess or as a single carbohydrate (10) , and large amounts of unabsorbed fructose may modulate physiology and metabolism of the digestive tract, we also measured the gut markers in response to applied dietary treatment. The gastrointestinal side effects of strawberries were anticipated as a result of fiber intake in the form of a berry pomace, whereas the fiber matcher present in both control groups was cellulose.
Materials and Methods
Plant material. Strawberry pomace was a mixture of cultivars from the 2007 season obtained after pressing fruits for juice in ALPEX. Seeds were removed and remaining material was air dried for 8 h at 708C and granulated to pellets of 0.5-2.0 mm (Lab-mill 1 QC-114, Labor-MIM). Two types of preparations were used for supplementation of experimental diets: natural and extracted strawberry pomace (Supplemental Fig. 1 ). Identification and quantification of individual phenolic compounds in both pomaces were performed with HPLC using a Dionex system equipped with a diode array detector (Dionex) coupled with a Gemini 5u C18 110A column (250 mm 3 4.6 mm; Phenomenex). Phase A consisted of 0.05% phosphoric acid in water, phase B consisted of 0.05% phosphoric acid in acetonitrile, and analysis was performed with a column temperature of 258C and a flow rate of 1.25 mL/min. The total concentration of polyphenols equaled 16.8 mg/g for US and 5.5 mg/g for PS ( Table 1) . In both preparations, ellagitannins were the predominant phenolic constituents, accounting for 84.5% in native and 73.6% in extracted pomace. Apart from phytochemicals, both supplements were a source of fruit fiber, where the soluble fraction constituted 2.9% in US and 3.3% in PS.
Rats and diets. The experiment was conducted on 48 male Wistar rats (171 6 2 g) supplied by the Charles River Laboratories. During the 4 wk of the dietary treatment, rats were housed individually in cages under controlled conditions (21 6 18C, relative humidity 50-70%) on a 12-hlight/-dark cycle. The group-specific diet (based on AIN-93 diet) (11) ( Table 2 ) and tap water were freely available. The rats were randomly divided into 6 groups of 8 animals each. The corn starch (CS), corn starch and unprocessed strawberry pomace (CS+US), and corn starch and processed strawberry pomace (CS+PS) groups received the diet based on corn starch whereas fructose was the main carbohydrate in the control with fructose (F) and in diets of the fructose and processed strawberry pomace (F+PS) and fructose and unprocessed strawberry pomace (F+US) groups. Treatment diets were modified with strawberry pomace (US or PS) (7.7%) added at the expense of soybean protein isolate, part of the cellulose, and corn starch. All diets had equilibrated amounts of dietary protein, fiber, and polyphenols, if any. Rats were treated according to The Guide for Care and Use of Laboratory Animals NIH and the study protocol was approved by the Institutional Animal Care and Use Committee in Olsztyn (Poland).
Individual feed consumption and BW gains of rats were determined. Rats were deprived of feed overnight (10-12 h) prior to anesthesia with sodium pentobarbitone (60 mg/kg of BW). Blood was collected from the caudal vein and serum was prepared by solidification and low-speed centrifugation (350 3 g, 10 min, 48C). Serum samples were kept frozen at 2408C until assayed. Selected internal organs (kidneys, heart, liver, and cecum with contents) were removed, weighed, and preserved for further investigations. Samples of fresh digesta were used for analyses immediately after their removal (pH and ammonia), whereas the concentration of SCFA was performed after sample storage at 2408C.
Analytical procedures. The pH in the intestinal content was measured using a microelectrode and pH/ION meter (model 301, Hanna Instruments). Ammonia concentration was determined in Conway dishes according to the method described by Hofirek and Haas (12) . The concentration of SCFA in the cecal content was analyzed by using GC (Shimadzu GC-2010; Shimadzu), previously described in detail (13) . Values for the cecal SCFA pool were calculated as the sum of the SCFA concentration and cecal digesta per 100 g of BW.
Lipid peroxidation products in the tissue of the internal organs were assessed by reaction with thiobarbituric acid as TBARS, according to the method of Uchiyama and Michara (14) . Liver lipids were extracted according to Folch et al. (15) . Following extraction, TC and TG concentrations were determined enzymatically using commercial kits (Cholesterol DST and Triacylglycerols DST, Alpha Diagnostic). To measure the rate of CD formation, lipid extracts were redissolved in 5 mL of methanol and the ratio of absorbance at 233 nm to that at 215 nm was calculated (A 233 :A 215 ) using a UV spectrophotometer (Heliosa, Unicam). The concentration of LP in the liver of rats was determined as described earlier (16) and the results were expressed as relative fluorescence per gram of tissue.
Serum samples were assessed for concentrations of glucose and lipids, including TC, TG, and HDL-C using a direct-measurement assays (Glucose OXY DST, Total Cholesterol DST, Triacylglycerols DST, and HDL-Cholesterol DST, Alpha Diagnostic). The AI of a diet was calculated for each animal according to the formula AI = log (TG/ HDL-C). The amount of FFA present in serum of rats was assessed through a coupled reaction to measure nonesterified fatty acid with a commercially available detection kit (Serum/Plasma Non-Esterified Fatty Acids Detection kit, Zen-Bio). Serum activities of AST and ALT were determined using laboratory kits obtained from Randox Laboratories (AST GPT and ALT GPT). CRP was assessed with a high-sensitivity, double polyclonal antibody sandwich enzyme immunoassay (Rat C-Reactive Protein ELISA Kit, Chemicon International). To measure insulin concentration, a validated rat insulin ELISA kit was used (Rat Insulin Enzyme Immunoassay Kit, Bertin Technologies). HOMA-IR was calculated according to the following formula: HOMA-IR = [fasting insulin (mU/L) 3 fasting glucose (mmol/L)/22.5]. Measurement of fructosamine was performed via a modified colorimetric method using Fructosamine Reagent Set (Pointe Scientific). The ACW and ACL substances (ACW-Kit and ACL-Kit; Analytik Jena) were determined by a photochemiluminescence detection method (17) using a Photochem analyzer (Analytik Jena). Ascorbic acid and Trolox calibration curves were used to evaluate ACW and ACL, respectively, and the results were expressed as mmol ascorbic acid or Trolox equivalent/L serum. Statistical analysis. The STATISTICA software version 6.0 (StatSoft) was used to determine whether variables differed among treatment groups. Two-way ANOVA was applied to assess the effects of strawberry product processing (S) (unprocessed and processed pomace), (D) (corn starch and high fructose), and the interaction between investigated factors (S 3 D). When the ANOVA indicated significant treatment effects, means were evaluated using Duncan's multiple range test. In the tables, results are presented as the mean values with their pooled SEM. Data were checked for normality before statistical analysis was performed. Differences with P # 0.05 were considered significant.
Results
BW gain and internal organ mass. Experimental diets did not affect BW gain or feed intake ( Table 3) . Rats in groups F, F+US, and F+PS had enlarged liver and kidneys compared to those receiving a diet based on starch (P , 0.001). Strawberry preparations did not decrease liver mass, whereas dietary supplementation with PS in groups CS+PS and F+PS reduced the weights of the kidneys compared with those of both control groups (P , 0.05).
Gastrointestinal indices. Regardless of the type of dietary carbohydrate, addition of strawberry pomace influenced the pH of the cecal content ( Table 4 ). The incorporation of pomace rich in polyphenols in the diet led to a decrease in pH value of the digesta in groups F+US and CS+US (P , 0.05 vs. CS and F). Both types of diet and supplementation affected ammonia concentration in the cecal digesta and for this marker there was an interaction between S and D (P , 0.005). Between rats fed unsupplemented diets, group CS had a higher ammonia content in the cecum compared to the F group (P , 0.01). However, administration of both investigated preparations lowered the concentration of ammonia to a level that did not differ among all 4 groups receiving diets with supplementation (P , 0.001). The SCFA pool was not affected by the diet type; however, supplementation with strawberry, especially with US, elevated the pool of 3 main fatty acids (acetate, propionate, and butyrate) and total SCFA in groups CS+US and F+US (P , 0.05).
Blood serum biomarkers. Different experimental treatments did not substantially modify concentrations of glucose, fructosamine, or CRP in the serum of rats (Supplemental Table 1 ). Both type of diet and berry supplement affected concentration of serum insulin (Table 5) , and the 2-way ANOVA revealed an interaction between D and S (P , 0.05). The diet high in fructose induced an almost 2-fold increase in the insulin concentration compared with the starch diet (P , 0.001). Among rats fed fructose, only those from the F+US group had normalized insulinemia (P # 0.05). Similarly, HOMA-IR values were higher in rats fed fructose than in those receiving starch (P , 0.005). Among fructose-overfed rats, supplementation with US was associated with a reduced insulin resistance index compared to the F+PS group (S 3 D, P , 0.05). High amounts of dietary fructose caused a higher serum FFA level than that observed after CS treatment (P # 0.001). Irrespectively of the type of diet, inclusion of the US led to a decrease of FFA in serum (P , 0.05 vs. unsupplemented treatments). TC and TG were both elevated (P , 0.005) in the serum of rats fed a diet high in fructose. The addition of the US to the diet of the CS+US and F+US groups lowered the TG concentration compared to rats from unsupplemented groups (P , 0.05) but did not affect TC. Experimental treatments did not affect levels of serum HDL-C. Interestingly, D and S each had an impact on the AI of rats (P , 0.001 and P , 0.05, respectively). AI values were higher among rats fed the high-fructose diet than among those receiving starch. US added to the diet reduced the value of AI but only in the CS+US group (P , 0.05). No significant differences in AST activity were found between the experimental groups. In contrast, the F group had significantly higher ALT activity compared to the other groups. In fructose-fed rats, the administration of US, and to a lesser degree PS, was associated with reduced serum ALT levels (P , 0.05).
Hepatic indices. In the liver, the concentrations of TG and TC were modified by both the type of sugar and by supplementation (Table 3 ) and, in terms of these biomarkers, there was an interaction between D and S (P , 0.001). Rats from groups receiving a diet high in fructose had a higher level of TG and TC in the liver (P , 0.001) compared to those fed starch. Irrespective of the strawberry supplementation, there were no significant differences in the concentration of hepatic TG between the 3 starch-fed groups. In contrast, the addition of both investigated preparations to the high-fructose diet substantially decreased the TG level in the livers of rats from groups F+US and F+PS. Similarly, TC was decreased after strawberry supplementation in a high-fructose diet; however, US exerted a stronger hypocholesterolemic effect.
Antioxidant protection. Heart was the only organ among those tested in which dietary treatment affected the concentration of TBARS (Table 3) . Furthermore, for this marker, a strong interaction between S and D was shown (P , 0.05). When rats were fed a diet high in fructose, their hearts had a higher TBARS content (P , 0.001); however, the administration of both Protective effects of strawberry preparations 1779
pomaces decreased the rate of TBARS formation in groups F+US and F+PS. LP deposits in the liver cells of rats varied upon experimental treatments. Statistical analysis revealed the correlation between the 2 variables (S and D) for the concentration of liver LP (P , 0.05). Fructose feeding led to an accumulation of LP in rats' liver (P , 0.001) and none of the applied supplements were able to reduce it. Surprisingly, among starch-fed rats, those from the CS+PS group had the highest level of LP in hepatocytes (P , 0.05); however, it was not as high as that observed in rats from the F group. The type of diet did not influence the content of the liver CD; however, among groups fed fructose, the addition of US lowered CD production in the organ, pomace containing fewer polyphenols caused a slightly smaller decrease in the CD concentration (S 3 D; P , 0.05). Inclusion of berry supplements proved to have a notable influence on serum ACW and ACL concentrations (P , 0.001). In the fructose-fed rats, unprocessed, and to a lesser degree processed, strawberry preparation increased the serum ACW level. Similarly, the highest concentration of ACW among rats fed a starch diet was in the CS+US group (S 3 D; P , 0.05). For both types of diets, both 3 SD for all rats divided by the square root of rat number, n = 48. 4 Nonsignificant, P . 0.05. types of strawberry supplements elevated ACL level (S 3 D; P , 0.001), but among starch-fed rats, the antioxidant effect was more pronounced when the diet was supplemented with US (CS +US . other groups; P , 0.05).
Discussion
The results of the current experiment support findings regarding kidney and liver hypertrophy associated with higher fructose intake (7, 9, 18) . Fructose is avidly metabolized in the liver and its metabolism has a highly lipogenic character (19, 20) ; thus, the liver enlargement observed here may be attributed to the increased fat accumulation in the organ. Strawberry supplementation did not reverse changes in liver mass that occurred in fructose-overloaded rats; however, it lowered the weight of the kidney to the level observed in starch-fed animals. An increase in the weight of the kidney cortex is often accompanied by renal functional changes and is a common feature in type 2 diabetes (21). High fructose consumption induces hyperuricemia, a condition that is closely associated with kidney insufficiency (22) . Although we have not measured any biomarkers that are characteristic of renal failure, it can be expected that 60% of dietary fructose resulted in functional alterations in this organ, which indirectly indicates an enlargement of its tissue. The complex dietary fiber polyphenols from PS was more efficient in decreasing renal masses. Moreover, the addition of strawberry pomace to the rats' diet decreased cecal bacterial ammonia generation, which most likely influenced the blood urea concentration. Thus, we hypothesize that fermentable carbohydrates were the active components that were responsible for the beneficial effect of berry supplementation in the management of diet-induced changes in the kidney. Hepatic pathology associated with disturbed lipid metabolism is frequently observed in experimental animals fed fructoseenriched diets (8, 9) . In this study, despite unreduced organ weight, feeding rats a diet supplemented with strawberry preparations partially prevented liver TC and TG accumulation. Moreover, strawberry reversed in part experimentally induced abnormalities in serum lipids, which was manifested by the reduction of an elevated serum TG level. Of note is the fact that the antihyperlipidemic action of the strawberry was detected among rats receiving both supplements; however, the liver TCand serum TG-lowering effect was stronger for the preparation abundant in polyphenols. In the study by Basu et al. (4), 4-wk consumption of freeze-dried strawberry powder significantly lowered levels of blood lipids in women with metabolic syndrome. Moreover, ellagic acid, which is also one of the main phenolic constituents of the investigated pomace, was shown to possess hypolipidemic activity, reducing plasma TG and TC in rabbits after high-fat and -cholesterol dietary treatment (23) . The possible mechanism explaining reduced hyperlipidemia and hepatic fat storage after berry supplementation may involve a strawberry-mediated effect on high fructose-induced alterations in metabolic biomarkers accompanying the insulin resistance state. Systemic insulin resistance can be a major causative factor in fatty liver development, because it elevates blood glucose, insulin, and FFA, which stimulate lipid synthesis in the liver and inhibit fatty acid oxidation (24, 25) . Even though we did not report changes in serum glucose and serum glycated proteins at the end of the study, this finding was previously documented in a similar experimental model in which fructose ingestion was associated with hyperinsulinemia instead of hyperglycemia (18) . Fructose stimulates the production and secretion of insulin from the pancreatic b cells less than does glucose (26) . Therefore, we suppose that the increase in serum insulin concentration observed here is associated with the development of insulin resistance. The likelihood of such a cause is further supported by elevated values of the insulin resistance index in fructose-fed rats. Higher values of insulinemia and HOMA-IR with concomitant normoglycemia observed in rats receiving fructose are likely to reflect an initial phase of insulin resistance, where compensatory hyperinsulinemia is able to maintain a normal level of circulating glucose, simultaneously inducing dyslipidemia and hepatosteatosis in those rats. Bioactive compounds from the US reduced the insulin concentration and HOMA-IR values in both fructose-and starch-fed rats. Hypoinsulinemic action of strawberry polyphenols was also reported in an experiment involving overweight men and women whose elevated levels of insulin in response to high-fat meals tended to be lower after strawberry administration (4) . In the present study, similar to what has been observed before (7), fructose overnutrition was linked with the marked increase in the level of circulating FFA. Both strawberry preparations were able to reduce FFA concentration in groups receiving fructose. Still, the decreasing effect was greater in animals receiving pomace with a higher amount of polyphenols. As was shown in a recent in vitro experiment (27) , polyphenol-rich extract from a range of berries, including strawberry, is an effective inhibitor of pancreatic lipase, an enzyme responsible for braking down fat into FFA. It therefore may be reasonable to consider that bioactive compounds present in the berry supplement were able to suppress dietary fat absorption from the small intestine of rats by inhibiting pancreatic activity, which resulted in the decreased lipid content observed in serum and liver tissue of rats. Based on the results obtained in this study for the two types of pomaces, we assume that an improvement in the lipid profile of rats following supplementation with strawberry may be ascribed to the phytochemicals present in the fruit and in part to its soluble fiber content, which was noted earlier to reduce serum and liver cholesterol (28, 29) . The mechanism by which strawberry fiber exerts its hypolipidemic effect may include decreased fat digestion and absorption in the gastrointestinal tract as well as the suppression of endogenous cholesterol biosynthesis. Soluble dietary fiber fractions, and to some extent insoluble as well, undergo cecal bacterial fermentation, resulting in SCFA synthesis, which is known to influence lipid metabolism. Cecal digesta of animals fed a diet supplemented with pomace, especially unprocessed one, had an elevated pool of the three principal fatty acids and total SCFA, which resulted in acidic pH in that part of the intestine. Acetate and propionate are known to oppositely influence fat metabolism; acetate seems to promote lipogenesis in the liver, whereas propionic acid has been reported to inhibit hepatic fatty acid synthesis (30) . SCFA can also influence lipid metabolism through regulation of fat absorption from the small intestine into the circulation; it has been demonstrated in an in vitro experiment that butyrate impairs lipid transport in Caco-2 cells (31) .
There is evidence that ROS contribute to the pathophysiology of metabolic syndrome and high fructose consumption often has been linked to oxidative stress (7, 20) . In the current study, fructose-treated rats exhibited some signs of oxidative stress as well, which was manifested in increased levels of heart TBARS and liver LP. Earlier findings indicate that the high antioxidant properties of strawberries are the result of their polyphenolic content (3, 4) and reduced oxidative damage to lipids following strawberry intake has been previously documented (4) . Here, strawberry supplementation resulted in partial protection against the prooxidant effect of a diet as shown by the decreased content of heart TBARS in groups F+US and F+PS compared with the F group. Formation of LP is promoted in oxidative stress and its accumulation negatively affects cellular function and homeostasis (32) . It has been noted that various antioxidants, including polyphenols, retard LP accumulation in different tissues (33) ; however, in the present study, the addition of berry supplement was not accompanied by a decreased level of LP in the liver tissue of rats. Nonetheless, an inhibitory effect of the tested preparation on hepatic lipid peroxidation was manifested by the reduced concentration of CD in the liver of rats receiving supplements. As was reported earlier (34), procyanidins are highly potent in preventing CD formation. The CD-decreasing effects observed in our study appeared to be more pronounced when the high-fructose diet was supplemented with the US preparation compared to the PS preparation. Additionally, although analysis of blood nonenzymatic antioxidant markers applied in our experiment did not demonstrate that the diet regimen providing 60% of energy from fructose negatively altered the serum oxidant status of rats, strawberry supplement, especially unprocessed, effectively increased serum ACW and ACL compared with animals receiving unsupplemented diets. This seems to further support the assumption about strawberry phenolics having a strong antioxidant potential.
Liver with high-fat content overproduces biomarkers of inflammation (35) and dietary fructose has been documented to induce abnormal inflammatory responses in experimental animals (36) . Elevated concentrations of circulating ALT and AST have been attributed to hepatosteatosis; these enzymes are released into the bloodstream when the liver is inflamed or injured (37) . Polyphenolic fractions of berries, especially tannins, have been reported to suppress the inflammatory response both in culture cells and in vivo (38, 39) . Intrahepatic fat accumulation is followed by a cascade of prooxidative events that are known to impair mitochondrial oxidation and organ function (35) . Because the liver is the major site of polyphenol metabolism and antioxidants can neutralize ROS, we suspect that a decrease in ALT activity in the F+US group is most likely a consequence of an increased influx of strawberry antioxidants to the liver. The biological plausibility of such a mechanism is supported by a previous study where ellagic acid proved to be protective against concanavalin-induced serum aminotransferase elevation, simultaneously inhibiting mitochondrial production of ROS in the livers of mice (38) .
The inflammatory marker CRP is also relevant in this context, given its hepatic origin and elevated concentrations in metabolic syndrome (40) . In our study, there was a lack of significant effect of dietary treatment on CRP level. Future studies on the diet-inflammation relationship should include the analysis of a broader spectrum of biomarkers, e.g. IL-6 and TNFa. These cytokines are known to regulate CRP (41) , so changes in their levels would probably more accurately reflect the inflammatory status of the host.
In summary, 4 wk of high fructose administration was a sufficient period of time to induce several metabolic perturbations associated with metabolic syndrome or diabetes. Although the biochemical effects of the unprocessed preparation in the normalization of the majority of dietary-induced disturbances were more pronounced than those of the pomace remaining after extraction, the results obtained in this study indicate that both strawberry pomaces were able to partially reverse these changes. In addition to the evidence for the protective action of polyphenols and fiber mediated by berries in rats, further studies are needed to assess the possible role of these compounds in the prevention of metabolic disorders in humans. In the meantime, giving preference to foods that are high in naturally occurring phytocompounds seems to represent an easy way to further improve human dietary habits. and M.W. conducted the research; M.W. and J. Jaroslawska analyzed the data; J. Jaroslawska wrote the paper; and Z.Z. had primary responsibility for the final content. All authors read and approved the final manuscript.
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